STOCK TITAN

Ispire Technology (ISPR) 8-K Filings

ISPR NASDAQ

Here are the 8-K filings from Ispire Technology Inc. (ISPR) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

An 8-K covers material events a company has to report between its quarterly reports, so if you follow ISPR and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ISPR filings page.

Rhea-AI Summary

Ispire Technology Inc. (ISPR) published an updated investor presentation reporting $26.7 million in Q4 FY2026 revenue, up 33% from $20.1 million in Q4 FY2025. It lists $96 million in trailing-12-month revenue as of June 30, 2026, operating expenses down 28.6% year over year, a $6.8 million year-over-year improvement in operating cash flow, and sequentially higher cash.

For Malaysia manufacturing, Ispire describes a 31,000-square-foot facility completed in February 2024 with seven production lines, and a 136,000-square-foot facility where production commenced in summer 2025. It lists total capacity of 61 million devices or 107 million pods per month using up to 70 production lines. Ispire says it holds Malaysia's only e-cigarette nicotine manufacturing license and one of two nicotine pouch manufacturing licenses.

Ispire identifies turning cash flow positive during January–December 2026 as a target tied to disciplined operational execution. It reports that nicotine and caffeine pouch ODM production commenced in April 2026. For IKE, its age-gating joint venture, Ispire says a component PMTA application was filed and accepted for review within one month in May 2025.

Rhea-AI Summary

Ispire Technology Inc. (ISPR) reported mixed fiscal fourth quarter and full-year 2026 results, showing strong revenue momentum but ongoing losses and a weakened balance sheet. For the quarter ended June 30, 2026, revenue rose to $26.7 million, up 32.5% year over year and 43% sequentially, as production and demand improved. However, gross profit fell to $1.7 million and gross margin declined to 6.3% from 12.3%, primarily due to inventory impairments. Total operating expenses were $15.2 million, down 11.1% from the prior-year quarter, and the net loss narrowed slightly to $13.8 million, with Adjusted EBITDA loss improving to $2.3 million from $4.4 million.

For fiscal 2026, revenue declined 24.7% to $96.0 million, driven by lower cannabis vaping hardware sales in the U.S. and reduced vaping product sales in Europe. Gross margin fell to 12.8% from 17.8%. Operating expenses were reduced by 26% to $44.9 million, and net loss improved to $33.2 million from $39.2 million, while Adjusted EBITDA loss improved to $4.0 million from $8.8 million. Net cash used in operating activities shrank sharply to $569,000 from $7.4 million, but the company ended the year with a stockholders’ deficit of $29.2 million and $47.0 million due to a related party. Management highlighted Malaysia manufacturing, Vapor ODM, IKE Tech age-gating and G-Mesh technologies, and a nicotine pouch joint venture as key growth catalysts for fiscal 2027, while cautioning that investments in Malaysia make the timing of reaching cash-flow positive performance less certain.

Rhea-AI Summary

Ispire Technology Inc. (ISPR) announced that its board appointed Steven Przybyla as President, effective immediately, while he continues as Chief Legal Officer and Secretary. His role adds a senior U.S.-based executive focus on regulatory strategy and investor communications, working directly with the CEO and CFO on material investor relations matters.

Przybyla has more than 10 years of nicotine and tobacco regulatory experience and previously helped secure the only Modified Risk Tobacco Product authorization for a combustible cigarette granted by the U.S. FDA to date. Under his existing employment agreement, he receives a $400,000 annual base salary with a 50% target bonus, at-will employment, and severance equal to 12 months of base salary plus accelerated vesting of 50% of unvested equity upon certain terminations. Ispire highlights his central role in its IKE Tech joint venture and its strategy to build compliance-focused technology infrastructure for regulated nicotine markets.

Rhea-AI Summary

Ispire Technology Inc. reports a leadership change in its top executive role. On July 16, 2026, the Board of Directors changed Michael Wang’s title to CEO of Aspire North America, a wholly owned subsidiary of the company. In connection with this change, Michael Wang no longer serves as Co-Chief Executive Officer of Ispire Technology Inc.

Following this transition, Tuanfang Liu is now the sole Chief Executive Officer of Ispire Technology Inc., consolidating the chief executive responsibilities at the parent-company level while Michael Wang continues in a senior leadership role at the subsidiary.

Rhea-AI Summary

Ispire Technology Inc. reported the results of its Annual Meeting of Stockholders held on June 23, 2026. On the April 24, 2026 record date, 57,399,396 common shares were outstanding, and 52,840,540 shares were represented in person or by proxy at the meeting.

Stockholders elected five directors — Tuanfang Liu, Jiangyan Zhu, Christopher Robert Burch, Brent Cox, and John Fargis — each to serve a one-year term until the 2027 annual meeting or until a successor is elected and qualified. Each nominee received over 39.9 million votes in favor and more than 11.7 million broker non-votes.

Stockholders also ratified the appointment of Marcum Asia LLP as independent registered public accounting firm for the fiscal year ending June 30, 2026, with 52,837,421 votes for, 2,704 against, and 415 abstentions, indicating strong support for the company’s choice of auditor.

Rhea-AI Summary

Ispire Technology (Nasdaq: ISPR) filed an 8-K detailing the results of its June 24, 2025 Annual Meeting.

  • Directors elected: Tuanfang Liu, Jiangyan Zhu, Christopher R. Burch, Brent Cox and John Fargis were re-elected for one-year terms. Support ranged from 98.7% to 99.7% of votes cast, with 9.47 million broker non-votes.
  • Auditor ratified: Marcum Asia LLP received 49,580,681 votes for (99.98%) and 7,657 against to serve for fiscal year ending June 30, 2025.
  • Quorum achieved: 49.59 million shares (86.8% of the 57.14 million outstanding) were present in person or by proxy.

No additional proposals or material business changes were reported.